期刊文献+

ER、PR、p53和HER2在正常子宫内膜和子宫内膜癌中的表达相关性分析 被引量:3

Analysis of corelation between ER PR P53 and HER2 expression in normal endometrium and endometrial carcinoma
原文传递
导出
摘要 目的研究ER、PR、p53和HER2在正常子宫内膜和子宫内膜癌中的表达。方法分别用HE染色和免疫组化SP法,对91例未接受过放、化疗及性激素治疗的子宫内膜癌患者标本,30例正常增生期子宫内膜标本进行染色,观察ER、PR、P53和HER2二者中的表达,并对这两种方法染色阳性表达进行比较。结果本研究中正常子宫内膜组织的30例,ER、PR阳性表达率分别为100%、90.0%,二者的双阳性率为90.0%,91例子宫内膜癌中,二者的双阳性率为47.2%。同时,ER在正常子宫内膜组织的阳性表达率为100%,ER在子宫内膜癌组织的阳性表达率为52.7%,提示与正常组比较,ER在子宫内膜癌组中表达减少,对实验数据进行量化分析表明:其差异有统计学意义(χ2=21.99,P<0.05,表2);PR在正常子宫内膜组织的阳性表达率为90.0%,PR在子宫内膜癌组织的阳性表达率为56.0%,提示与正常组比较,PR在子宫内膜癌组表达减少,对实验数据进行量化分析表明:其差异有统计学意义(χ2=11.36,P<0.05)。结论 ER、PR在子宫内膜癌组中蛋白表达降低。p53在子宫内膜癌组中的高表达,且其差异具有统计学意义(χ2=30.24,P<0.05)。HER2在子宫内膜癌组中的高表达,且其差异具有统计学意义(χ2=30.24,P<0.05)。 Objective To study the expression of ER,PR,P53 and HER2 in normal endometrium and endometrial carcinoma. Methods Using HE staining and immunohistochemistry of SP method,91 cases had not received,chemotherapy and hormone therapy of endometrial carcinoma,30 cases of normal proliferative endometrial samples were stained to observed the expression of Er,PR,p53,HER2 two,and of the two methods dye color positive expression were compared. Results Of this study in normal endometrial tissues of 30 cases,ER and PR positive expression rate of 100%,90. 0%,respectively,two double positive rate was 90. 0%,91 cases of endometrial carcinoma,two double positive rate was 47. 2%. At the same time,the positive expression of ER in normal endometrium was 100%,the positive expression of ER inendometrial carcinoma was 52. 7%,compared with the normal group,the reduction of the expression of ER in endometrial carcinoma group,the experimental data for quantitative analysis showed that: the difference was statistically significant( χ2= 21. 99,P〈0. 05,table 2); the positive expression of PR in normal endometrium was 90%,the positive expression of PR inendometrial carcinoma was 56%,compared with the normal group,the reduction of the expression of PR in endometrial carcinoma group,the experimental data for quantitative analysis showed that there were statistically significant differences between them( χ2= 11. 36,P〈0. 05). Conclusions ER,PR protein in endometrial carcinoma group decreased expression. The high expression of p53 in endometrial carcinoma group,and the difference was significant( χ2= 30. 24,P〈0. 05). The high expression of HER2 in endometrial carcinoma group,and the difference was significant( χ2= 30. 24,P〈0. 05).
作者 牛希贤
出处 《医药论坛杂志》 2015年第10期58-60,共3页 Journal of Medical Forum
关键词 ER、PR、p53、HER2正常子宫内膜 子宫内膜癌 表达 ER PR p53 and HER2 expression Normal endometrial Carcinoma of endometrium
  • 相关文献

参考文献8

  • 1American Cancer Society.Detailed guide:Endometrial cancer:What are the risk factors for endometrial cancer[J].Atlanta,Ga.American Cancer Society,2005.
  • 2林仲秋,吴珠娜.FIGO 2009外阴癌、宫颈癌和子宫内膜癌新分期解读[J].国际妇产科学杂志,2009,36(5):411-412. 被引量:79
  • 3林石清,万挺,刘继红.Ⅰ期子宫内膜癌患者的循证治疗方案[J].广东医学院学报,2009,27(6):617-619. 被引量:3
  • 4徐从高 张茂宏 杨兴季.癌-肿瘤学原理和实践[M].济南:山东科学技术出版社,2001.254.
  • 5Hoffman WH,BiadeS,Zilfou JT,et al.T ranscripti on al re-pression of the ant-i apopto ticsu rvi vin gene by wild type p53[J].J B-iol Chen,2002,277(5):3247-3257.
  • 6Tavassoli FA,Devilee P.World H ealth Organizat ion cl as sifi cation of tumours,patholo-gy and genetics of tumours of the breastand female genit al organs[M].Lyon:LARCpress,2003:236-242.
  • 7Paulett iG,Godo Iph inW,PressMF,et al.Detection and quan-titation ofHER-2/neu gene amplification in human b reast cancer archival material us ing fluorescence insitu hyb rid izat ion[J].Oncogene,2003,13(1):63-72.
  • 8Casalini P,Botta L,Menard S.Role of p53 in HER2-induced Proliferation or Apoptosis[J].J Biol Chem,2001,276(15):12449-12453.

二级参考文献13

  • 1Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium [J]. Int J Gynaecol Obstet, 2009, 105 (2): 103-104.
  • 2Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2) : 74-108.
  • 3Garcia M, Jemal A, Ward E M, et al. Global cancer facts & figures 2007 [R]. Atlanta, GA: American Cancer Society, 2007.
  • 4卫生部统计信息中心.2008年中国卫生统计提要:2004-2005年前十位恶性肿瘤死亡率[EB/OL].http://www.moh. gov. cn/ publicfiles/ business/ htmlfiles/zwgkzt/ptjty/ 200805/35671. htm.
  • 5Kitchener H. Management of endometrial cancer [J]. Eur J Surg Oncol, 2006, 32(8): 838-843.
  • 6Gernignani M L, Curtin J P, Zelmanovich J, et al. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges [J]. Gynecol Oncol, 1999, 73(1): 5-11.
  • 7Holub Z, Jabor A, Bartos P, et al. Laparoscopic surgery for endometrial cancer: long-term results of a multicentric study [J]. Eur J Gynaecol Oncol, 2002, 23(4): 305-310.
  • 8Malur S, Possover M, Michels W, et al. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer-a prospective randomized trial [J]. Gynecol Oncol, 2001, 80(2): 239-244.
  • 9Kuoppala T, Tomas E, Heinonen P K. Clinical outcome and complications of laparoscopic surgery compared with traditional surgery in women with endometrial cancer [J], Arch Gynecol Obstet, 2004, 270(1):25-30.
  • 10Takeshima N, Hirai Y, Tanaka N, et al. Pelvic lymphnode metastasis in endometrial cancer with no myometrial invasion [J]. Obstet Gynecol, 1996, 88(2): 280-282.

共引文献96

同被引文献22

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部